Covering the Cover Gastroenterology Anson W. Lowe, Richard H. Moseley  Gastroenterology  Volume 145, Issue 3, Pages 493-495 (September 2013) DOI: 10.1053/j.gastro.2013.07.036 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Effect of the sweetening agent. (A) Independently of carbonation, sucrose increased (yellow-red) activity compared with As-Ac in Amy and As-Ac increased activity in AI. (B) Differential brain activity for sucrose versus As-Ac was more evident without than with CO2 and diffusely in favor of sucrose (left OTC, MTC, and OFC). (C) CO2 reduced differential brain activity, which was higher for As-Ac in AI, OTC, ITC, and OFC. Amy, amygdala; AI, anterior insula; ITC, inferior temporal cortex; MTC, mesial-temporal cortex; OFC, orbitofrontal cortex; OTC, occipitotemporal cortex. Gastroenterology 2013 145, 493-495DOI: (10.1053/j.gastro.2013.07.036) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Propensity for organ-specific metastasis of oncospheres derived from nonmetastasizing tumor (CRC108), or metastasis from the liver (CRC108-LM) or lung (CRC108-PM). Gastroenterology 2013 145, 493-495DOI: (10.1053/j.gastro.2013.07.036) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Effects of ONO1301, Beraprost, Ozagrel, and Telaprevir on the expansion of bbHCV-infected urokinase plasminogen activator/severe combined immunodeficiency mice bearing human hepatocytes. Data are presented as means ± SD for 6 (control, diamonds), 4 (ONO1301, squares; Ozagrel, crosses; Telaprevir, asterisk), and 3 (Beraprost, triangles) samples. *Differs from control, P < .05. Gastroenterology 2013 145, 493-495DOI: (10.1053/j.gastro.2013.07.036) Copyright © 2013 AGA Institute Terms and Conditions